JCM | Free Full-Text | Looking for a Tailored Therapy for Heart Failure: Are We Capable of Treating the Patient Instead of the Disease? | HTML
Ivabradine: a new rate-limiting therapy for coronary artery disease and heart failure | Semantic Scholar
Zeolitic Metal Cluster Carboxylic Framework for Selective Carbon Dioxide Chemical Fixation through the Superlarge Cage | Inorganic Chemistry
Clinical use of ivabradine in the acute coronary syndrome: A systematic review and narrative synthesis of current evidence - ScienceDirect
Effect of ivabradine on major adverse cardiovascular events and mortality in critically ill patients: a systematic review and meta-analyses of randomised controlled trials with trial sequential analyses - British Journal of Anaesthesia
Untitled
Secondary Prevention Beyond Hospital Discharge for Acute Coronary Syndrome: Evidence-Based Recommendations - Canadian Journal of Cardiology
Clinical use of ivabradine in the acute coronary syndrome: A systematic review and narrative synthesis of current evidence - ScienceDirect
Ivabradine and AF: Coincidence, Correlation or a New Treatment? | AER Journal
Biomedicines | Free Full-Text | Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System
The ESC 2019 CCS guidelines: Have we left our patients and scientific evidence behind? - European Journal of Internal Medicine
Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study - International Journal of
Randomised, Double-Blind, Placebo-Controlled Trial of Ivabradine in Patients with Acute Coronary Syndrome: Effects of the I f Current Inhibitor Ivabradine on Reduction of Inflammation Markers in Patients with Acute Coronary Syndrome—RIVIERA Trial
Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneo
Complementary and Synergic Role of Combined Beta-blockers and Ivabradine in Patients with Chronic Heart Failure and Depressed Systolic Function: A New Therapeutic Option? | CFR Journal
Ivabradine in acute coronary syndromes: Protection beyond heart rate lowering - International Journal of Cardiology
Flow chart of SHIFT-AHF trial. ACS, acute coronary syndrome; TIA,... | Download Scientific Diagram
Monodispersed MOF-808 Nanocrystals Synthesized via a Scalable Room-Temperature Approach for Efficient Heterogeneous Peptide Bond Hydrolysis | Chemistry of Materials
